Posts in category
Science watch, reports and news on toxicology trainings
Press Releases / PLENARY SESSIONhttps://www.europarl.europa.eu/news/en/press-room/20210910IPR11926/meps-demand-eu-action-plan-to-end-the-use-of-animals-in-research-and-testingAnimal testing for cosmetic products prohibited in the EU since 200912 million animals were still bred and killed for animal testing in 2017More funding for alternative testing methods neededMinimise pain, distress and suffering of animals when their use cannot be avoided"Parliament urges the EU to accelerate the transition to a research…
During the next Plenary session in the middle of September, MEPs will cast their vote on an important text for the future of the 10 millions laboratory animals used yearly in the EU. The Motion for a resolution calls for an Action Plan to facilitate the transition to innovation without the use of animals in research,…
Altertox Academy is contributing in two granted projects by European Commission JRC EURL ECVAM with one of them is about building an inventory of worldwide 3Rs education & training resources
The French Society of Toxicology (SFT) and Altertox Academy (ex-CAAT Academy) have reached an agreement in regard to the Altertox Academy laboratory trainings for the period between 2018 and 2019. With this official partnership, the SFT acknowledges that trainings developed under Altertox Academy provide valuable toxicological insights for continuing professional development and a participation at the same…
Physiologically-Based Pharmacokinetic Modelling in Virtual Human Populations and Preclinical Species. Monday 16th October, 2017 – Simcyp (a Certara® company) Certara® is the leading provider of decision support technologies and consulting services for optimizing drug development and improving both health, and safety outcomes. Simcyp (a Certara® company) develops and provides mechanistic, physiologically-based pharmacokinetic (PBPK) modelling services…
Relevant and standardizable in vitro test systems Friday 29th September, 2017, Regina Grillari & Matthias Wieser from Evercyte GmbH Evercyte, an innovative biotechnology spin-out company from the University of Natural Resources and Life Sciences Vienna, is focused on the establishment of human cell cultures that fulfill all conditions for the performance of state-of-the-art toxicity studies,…
Wednesday 27th September, 2017 - TissUse TissUse is a vibrant Berlin, Germany-based, growth company, which has developed a unique “Multi-Organ-Chip” platform that provides unparalleled preclinical insight on a systemic level using human tissue. This enabling technology platform consists of a miniaturized construct that closely simulates the activity of multiple human organs in their true physiological…
In vitro models for hepatic drug handling and drug-induced cholestasis Tuesday 25th June, 2017 - Pieter Annaert & the hepatic drug disposition group at the KU Leuven The hepatic drug disposition group at the KU Leuven Drug Delivery and Disposition Lab has many years of experience in the development and application of in vitro models…